PPBT

Conviction 0HealthcareScan · Thu, Sep 24, 2026

Purple Biotech Ltd. (PPBT) closed at $1.45 (-2.36%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 40, RS Rating 6, -86.3% from its 52-week high, -78.0% year to date. Sector: Healthcare · Pharmaceutical Preparations.

PPBT$1.45-2.36%

ResistanceSupportVol 14

Vol MA14 115.69K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

PURPLE BIOTECH LTD.Pharmaceutical Preparationswww.purple-biotech.com ↗

Price1.45

Change-2.36%

Gap-1.01%

Rel volume0.02×

Avg volume3.98M

Avg $ vol7.85M

SMA 201.67

SMA 501.56

SMA 2003.79

Price vs 50-6.84%

Price vs 200-61.71%

MA stackbearish

50/200 cross—

Supertrenddown · 1.99

RSI (14)40

MACD hist-0.04

MACD crossbear · 7d

Stoch %K / %D14 / 14

ADX (14)19

+DI / −DI20 / 23

RSI divergence—

MACD divergence—

ATR %12.30%

ADR %11.89%

52w high10.60

52w low1.33

From 52w high-86.32%

Above 52w low+9.02%

New 52w highNo

SqueezeOff

Bollinger width39.29%

%B0.17

Donchian pos8.57%

Donchian high2.59

Donchian low1.34

AVWAP (52w high)4.88

vs AVWAP high-70.28%

AVWAP (52w low)2.13

vs AVWAP low-32.00%

OBV trendUp

Chaikin MF (20)-0.74

Today vs 20d0.02×

Avg vol (14d)115.69K

Avg vol (20d)3.98M

Avg $ vol (20d)7.85M

Market cap1.35M

RS Rating6 / 99

RS 3m (vs SPY)-21.63%

RS 6m (vs SPY)-81.79%

RS line new highNo

Trend template0/8

Technical rank13.9

1 week-6.15%

1 month-12.12%

3 months-17.14%

6 months-64.98%

1 year-74.99%

YTD-78.04%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target17.00

Target upside1072.41%

Analyst ratingBuy

Institutional0.00%

Ent. value1.35M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out1.01M

Employees10

ListedFri, Nov 20, 2015

Free float1.08M

Float %66.5%

Short interest28.12K

Days to cover0.9d

Short volume7.4%

Squeeze score10 / 100

Next earnings—

EPS forecast—

Last EPS vs est$1.07 vs −$0.98

Last surprise+209.2% beat

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank13.9 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.24

Support1.25

Days since event—

Candle confirm—

Congress activity

Disclosed STOCK Act trades in PPBT

All disclosures →

No recent disclosed trades by Congress in PPBT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PPBT

No recent insider (Form 4) filings in PPBT. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in PPBT · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.